Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor update to the page's revision history. This change does not alter study data, eligibility criteria, or user-facing content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedFooter/credits now include the Moffitt Cancer Center Clinical Trials website and the full institutional name, and the site revision is updated from v3.6.0 to v3.6.3.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now reflects that recruitment has ceased for participants, indicating the study is not actively enrolling. Added help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with minor formatting changes to the Intervention/Treatment label and a revision tag updated to v3.6.0.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page's revision stamp was updated from v3.5.4 to v3.5.5. This update modifies version metadata and does not change study details or user-visible content.SummaryDifference0.1%

- Check71 days agoChange DetectedFooter branding and versioning were updated: a new revision badge (Revision: v3.5.4) was added. Several footer lines referencing the sponsor/organization and the previous revision tag (Revision: v3.5.3) were removed.SummaryDifference0.2%

- Check93 days agoChange DetectedThe page’s revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a site or display update rather than a change to the trial information.SummaryDifference0.1%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.